DK70687A - Polycykliske quinolin, naphthyridin og pyrazinopyridinderivater - Google Patents

Polycykliske quinolin, naphthyridin og pyrazinopyridinderivater

Info

Publication number
DK70687A
DK70687A DK070687A DK70687A DK70687A DK 70687 A DK70687 A DK 70687A DK 070687 A DK070687 A DK 070687A DK 70687 A DK70687 A DK 70687A DK 70687 A DK70687 A DK 70687A
Authority
DK
Denmark
Prior art keywords
naphthyridine
polycyclic
pyrazinopyridine
derivatives
polycyclic quinoline
Prior art date
Application number
DK070687A
Other languages
Danish (da)
English (en)
Other versions
DK70687D0 (da
Inventor
Ashit Kumar Ganguly
John Herbert Schwerdt
Richard James Friary
Marvin Ira Siegel
Sidney Randall Smith
Vera Ann Seidl
Edmund J Sybertz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK70687D0 publication Critical patent/DK70687D0/da
Publication of DK70687A publication Critical patent/DK70687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK070687A 1985-06-13 1987-02-12 Polycykliske quinolin, naphthyridin og pyrazinopyridinderivater DK70687A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74486585A 1985-06-13 1985-06-13
US86178886A 1986-05-15 1986-05-15
PCT/US1986/001269 WO1986007359A2 (fr) 1985-06-13 1986-06-13 Derives polycycliques de quinoline, naphthyridine et pyrazinopyridine

Publications (2)

Publication Number Publication Date
DK70687D0 DK70687D0 (da) 1987-02-12
DK70687A true DK70687A (da) 1987-02-12

Family

ID=27114362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK070687A DK70687A (da) 1985-06-13 1987-02-12 Polycykliske quinolin, naphthyridin og pyrazinopyridinderivater

Country Status (19)

Country Link
EP (1) EP0229823B1 (fr)
JP (1) JPH0762017B2 (fr)
KR (1) KR900004831B1 (fr)
AT (1) ATE67764T1 (fr)
AU (1) AU591922B2 (fr)
CA (1) CA1306255C (fr)
DE (1) DE3681719D1 (fr)
DK (1) DK70687A (fr)
GR (1) GR861530B (fr)
HK (1) HK94694A (fr)
HU (1) HU203098B (fr)
IE (1) IE60420B1 (fr)
IL (1) IL79110A0 (fr)
MY (1) MY101808A (fr)
NO (1) NO168177C (fr)
NZ (1) NZ216519A (fr)
OA (1) OA08480A (fr)
PT (1) PT82752B (fr)
WO (1) WO1986007359A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609795A1 (de) * 1986-03-22 1987-09-24 Goedecke Ag Pyrido(4,3-b)(1,6)naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
US5366971A (en) * 1987-11-09 1994-11-22 Sandoz Ltd. Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
BR9507311A (pt) * 1994-04-08 1997-10-07 Prevue International Inc Guia de programa de rolagem interativo
NZ287139A (en) * 1994-06-14 1997-07-27 Dainippon Pharmaceutical Co Naphthyridine derivatives; preparative process and anti-tumour medicaments
ATE277017T1 (de) * 1999-08-30 2004-10-15 Maruishi Pharma 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
HU231285B1 (hu) 2018-04-18 2022-08-28 Printnet Kereskedelmi És Szolgáltató Kft. A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH498841A (fr) * 1967-07-13 1970-11-15 Inst Farmaceutyczny Procédé de préparation de benzo-(b,1,8)-naphtyridones-5 substituées
DE2803541A1 (de) 1978-01-27 1979-08-02 Sandoz Ag Neue chinolinderivate, ihre herstellung und verwendung
US4680298A (en) 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents

Also Published As

Publication number Publication date
NO168177B (no) 1991-10-14
NZ216519A (en) 1989-02-24
OA08480A (en) 1988-07-29
WO1986007359A3 (fr) 1987-04-09
PT82752B (pt) 1988-12-15
DK70687D0 (da) 1987-02-12
WO1986007359A2 (fr) 1986-12-18
DE3681719D1 (de) 1991-10-31
NO870564D0 (no) 1987-02-12
IL79110A0 (en) 1986-09-30
HU203098B (en) 1991-05-28
NO168177C (no) 1992-01-22
ATE67764T1 (de) 1991-10-15
KR870700622A (ko) 1987-12-30
AU591922B2 (en) 1989-12-21
IE861565L (en) 1986-12-13
HUT42482A (en) 1987-07-28
PT82752A (en) 1986-07-01
HK94694A (en) 1994-09-16
MY101808A (en) 1992-01-31
AU6122486A (en) 1987-01-07
KR900004831B1 (ko) 1990-07-07
NO870564L (no) 1987-02-12
GR861530B (en) 1986-12-31
EP0229823B1 (fr) 1991-09-25
CA1306255C (fr) 1992-08-11
JPH0762017B2 (ja) 1995-07-05
JPS63500518A (ja) 1988-02-25
IE60420B1 (en) 1994-07-13
EP0229823A1 (fr) 1987-07-29

Similar Documents

Publication Publication Date Title
IE800761L (en) Naphthyridines
NO864518D0 (no) Fremgangsmaate for fremstilling av thiazolo(4,5-c)kinoliner
FI881825A7 (fi) Uusien heterobisyklisten kinolonijohdannaisten valmistus.
NO875378L (no) Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater).
AU588958B2 (en) Opthlamic use of quinoline and naphthyridine antibiotics
FI882909A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten furanyylimetyylisubstituoitujen bentsimidatsoli- ja imidatsopyridiinijohdannaisten valmistamiseksi
DK70687D0 (da) Polycykliske quinolin, naphthyridin og pyrazinopyridinderivater
NO881333D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinderivater
FI883930L (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
FI893471A0 (fi) Menetelmä haavaumia ehkäisevien (alkyyliditio)kinoliinijohdannaisten valmistamiseksi
AU609389B2 (en) Aryl-substituted naphthydridine and pyridopyrazine derivatives
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
MY100071A (en) Aryl-substituted naphthyridine and pyridopyrazine derivatives
NO862220L (no) Fremgangsmaate og anordning for samtidig aktivering av navigasjonslanterner.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment